Sumit Kumar
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sumit Kumar has a total of 58 co-authors. Here are the top co-authors by number of shared publications:
- Yoon-Kyoung Cho
Department of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), Ulsan 44919, South Korea
9 shared publications Mamata Karmacharya
Ulsan National Institute of Science and Technology (UNIST)
5 shared publicationsElizabeth Maria Clarissa
Center for Algorithmic and Robotic Synthesis (CARS), Institute for Basic Science (IBS), Ulsan, South Korea
2 shared publicationsIssac Michael
Department of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), Ulsan, South Korea
2 shared publicationsOleksandra Gulenko
Department of Biomedical Engineering, Ulsan National Institute of Science and Technology (UNIST), Ulsan, South Korea
2 shared publications- Aelee Jang
Department of Nursing, University of Ulsan, Republic of Korea
1 shared publication
Latest Publications
- Open Access
- 23 October 2026
- Published by Springer Nature in Research Square
Conserved biological response states organize nanoparticle biosafety across neurological systems
Predicting biological outcomes of nanomaterials remains challenging because material properties alone do not capture context-dependent responses across exposure conditions and experimental systems. We develop a response-centred machine-learning framework that integrates heterogeneous biological responses into a Conserved Response Axis (CRA) associated with biosafety and recovery. Across 893 contexts from 599 neurological studies, integrating exposure and biological context with material properties increased ROC-AUC from 0.66 to 0.88 for biosafety and from 0.64 to 0.77 for recovery; incorporating cellular-response programmes further increased ROC-AUC to 0.90 and 0.78, respectively. Pro-inflammatory, anti-inflammatory and apoptosis-associated programmes formed coordinated patterns associated with biological outcomes. This organization was evaluated in unseen nanocomposites using 2D and 3D microglial models and independent brain, lung and liver transcriptomic datasets, supporting transferability across biological contexts. CRA identifies host-response states as a predictive layer beyond material and exposure descriptors, providing a basis for response-guided assessment and biology-informed nanomaterial design.
- 23 October 2026
- Published by Springer Nature in Research Square
Open AccessConserved biological response states organize nanoparticle biosafety across neurological systems
Predicting biological outcomes of nanomaterials remains challenging because material properties alone do not capture context-dependent responses across exposure conditions and experimental systems. We develop a response-centred machine-learning framework that integrates heterogeneous biological responses into a Conserved Response Axis (CRA) associated with biosafety and recovery. Across 893 contexts from 599 neurological studies, integrating exposure and biological context with material properties increased ROC-AUC from 0.66 to 0.88 for biosafety and from 0.64 to 0.77 for recovery; incorporating cellular-response programmes further increased ROC-AUC to 0.90 and 0.78, respectively. Pro-inflammatory, anti-inflammatory and apoptosis-associated programmes formed coordinated patterns associated with biological outcomes. This organization was evaluated in unseen nanocomposites using 2D and 3D microglial models and independent brain, lung and liver transcriptomic datasets, supporting transferability across biological contexts. CRA identifies host-response states as a predictive layer beyond material and exposure descriptors, providing a basis for response-guided assessment and biology-informed nanomaterial design.
- Open Access
- 3 March 2025
- Published by Springer Nature in Microsystems & Nanoengineering
- Vol. 11  (1) , 1-15
Nanoplasmonic SERS on fidget spinner for digital bacterial identification
Raman spectroscopy offers non-destructive and highly sensitive molecular insights into bacterial species, making it a valuable tool for detection, identification, and antibiotic susceptibility testing. However, achieving clinically relevant accuracy, quantitative data, and reproducibility remains challenging due to the dominance of bulk signals and the uncontrollable heterogeneity of analytes. In this study, we introduce an innovative diagnostic tool: a plasmonic fidget spinner (P-FS) incorporating a nitrocellulose membrane integrated with a metallic feature, referred to as a nanoplasmonic-enhanced matrix, designed for simultaneous bacterial filtration and detection. We developed a method to fabricate a plasmonic array patterned nitrocellulose membrane using photolithography, which is then integrated with a customized fidget spinner. Testing the P-FS device with various bacterial species (E. coli 25922, S. aureus 25923, E. coli MG1655, Lactobacillus brevis, and S. mutans 3065) demonstrated successful identification based on their unique Raman fingerprints. The bacterial interface with regions within the plasmonic array, where the electromagnetic field is most intensely concentratedâcalled nanoplasmonic hotspotsâon the P-FS significantly enhances sensitivity, enabling more precise detection. SERS intensity mappings from the Raman spectrometer are transformed into digital signals using a threshold-based approach to identify and quantify bacterial distribution. Given the P-FSâs ability to enhance vibrational signatures and its scalable fabrication under routine conditions, we anticipate that nanoplasmonic-enhanced Raman spectroscopyâutilizing nanostructures made from metals (specifically gold and silver) deposited onto a nitrocellulose membrane to amplify Raman scattering signalsâwill become the preferred technology for reliable and ultrasensitive detection of various analytes, including those crucial to human health, with strong potential for transitioning from laboratory research to clinical applications.
- 3 March 2025
- Published by Springer Nature in Microsystems & Nanoengineering
- Vol. 11  (1) , 1-15
Open AccessNanoplasmonic SERS on fidget spinner for digital bacterial identification
Raman spectroscopy offers non-destructive and highly sensitive molecular insights into bacterial species, making it a valuable tool for detection, identification, and antibiotic susceptibility testing. However, achieving clinically relevant accuracy, quantitative data, and reproducibility remains challenging due to the dominance of bulk signals and the uncontrollable heterogeneity of analytes. In this study, we introduce an innovative diagnostic tool: a plasmonic fidget spinner (P-FS) incorporating a nitrocellulose membrane integrated with a metallic feature, referred to as a nanoplasmonic-enhanced matrix, designed for simultaneous bacterial filtration and detection. We developed a method to fabricate a plasmonic array patterned nitrocellulose membrane using photolithography, which is then integrated with a customized fidget spinner. Testing the P-FS device with various bacterial species (E. coli 25922, S. aureus 25923, E. coli MG1655, Lactobacillus brevis, and S. mutans 3065) demonstrated successful identification based on their unique Raman fingerprints. The bacterial interface with regions within the plasmonic array, where the electromagnetic field is most intensely concentratedâcalled nanoplasmonic hotspotsâon the P-FS significantly enhances sensitivity, enabling more precise detection. SERS intensity mappings from the Raman spectrometer are transformed into digital signals using a threshold-based approach to identify and quantify bacterial distribution. Given the P-FSâs ability to enhance vibrational signatures and its scalable fabrication under routine conditions, we anticipate that nanoplasmonic-enhanced Raman spectroscopyâutilizing nanostructures made from metals (specifically gold and silver) deposited onto a nitrocellulose membrane to amplify Raman scattering signalsâwill become the preferred technology for reliable and ultrasensitive detection of various analytes, including those crucial to human health, with strong potential for transitioning from laboratory research to clinical applications.
- Open Access
Nature Inspired Delivery Vehicles for CRISPRâBased Genome Editing
The advent of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)âbased genome editing technologies has opened up groundbreaking possibilities for treating a wide spectrum of genetic disorders and diseases. However, the success of these technologies relies heavily on the development of efficient and safe delivery systems. Among the most promising approaches are natural and synthetic nanocarrierâmediated delivery systems, including viral vectors, extracellular vesicles (EVs), engineered cellular membrane particles, liposomes, and various nanoparticles. These carriers enhance the efficacy of the CRISPR system by providing a unique combination of efficiency, specificity, and reduced immunogenicity. Synthetic carriers such as liposomes and nanoparticles facilitate CRISPR delivery with high reproducibility and customizable functions. Viral vectors, renowned for their high transduction efficiency and broad tropism, serve as powerful vehicles for delivering CRISPR components to various cell types. EVs, as natural carriers of RNA and proteins, offer a stealth mechanism to evade immune detection, allowing for the targeted delivery of genome editors with minimal offâtarget effects. Engineered cellular membrane particles further improve delivery by simulating the cellular environment, enhancing uptake, and minimizing immune response. This review explores the innovative integration of CRISPR genome editors with various nanocarrier systems, focusing on recent advancements, applications, and future directions in therapeutic genome editing.
Open AccessNature Inspired Delivery Vehicles for CRISPRâBased Genome Editing
The advent of Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)âbased genome editing technologies has opened up groundbreaking possibilities for treating a wide spectrum of genetic disorders and diseases. However, the success of these technologies relies heavily on the development of efficient and safe delivery systems. Among the most promising approaches are natural and synthetic nanocarrierâmediated delivery systems, including viral vectors, extracellular vesicles (EVs), engineered cellular membrane particles, liposomes, and various nanoparticles. These carriers enhance the efficacy of the CRISPR system by providing a unique combination of efficiency, specificity, and reduced immunogenicity. Synthetic carriers such as liposomes and nanoparticles facilitate CRISPR delivery with high reproducibility and customizable functions. Viral vectors, renowned for their high transduction efficiency and broad tropism, serve as powerful vehicles for delivering CRISPR components to various cell types. EVs, as natural carriers of RNA and proteins, offer a stealth mechanism to evade immune detection, allowing for the targeted delivery of genome editors with minimal offâtarget effects. Engineered cellular membrane particles further improve delivery by simulating the cellular environment, enhancing uptake, and minimizing immune response. This review explores the innovative integration of CRISPR genome editors with various nanocarrier systems, focusing on recent advancements, applications, and future directions in therapeutic genome editing.
- Open Access
Digital Profiling of Tumor Extracellular Vesicle-associated RNAs Directly from Unprocessed Blood Plasma
Tumor-derived extracellular vesicle (tEV)-associated RNAs hold promise as diagnostic biomarkers, but their clinical use is hindered by the rarity of tEVs among non-tumor EVs. Here, we present EV-CLIP, a highly sensitive droplet-based digital method for profiling EV RNA. EV-CLIP utilizes the fusion of EVs with charged liposomes (CLIPs) in a microfluidic chip. Optimized CLIP surface charge enables exceptional sensitivity and selectivity for EV-derived miRNAs and mRNAs. This approach streamlines detection with minimal plasma volume (20 ÂľL) and eliminates the need for prior EV isolation or RNA preparation, preventing loss of EVs or RNA. In testing with 83 patient samples, EV-CLIP detected EGFR L858R and T790M mutations with high AUC values of 1.0000 and 0.9784, respectively. Its success in serial monitoring during chemotherapy highlights its potential for precise quantification of rare EV subpopulations, facilitating the exploration of single EV RNA content and enhancing understanding of diverse EV populations in various disease states. SUMMARY EV-CLIP: A highly sensitive digital method for tumor-derived EV RNA detection using undiluted blood plasma samples, promising for precise tumor management.
Open AccessDigital Profiling of Tumor Extracellular Vesicle-associated RNAs Directly from Unprocessed Blood Plasma
Tumor-derived extracellular vesicle (tEV)-associated RNAs hold promise as diagnostic biomarkers, but their clinical use is hindered by the rarity of tEVs among non-tumor EVs. Here, we present EV-CLIP, a highly sensitive droplet-based digital method for profiling EV RNA. EV-CLIP utilizes the fusion of EVs with charged liposomes (CLIPs) in a microfluidic chip. Optimized CLIP surface charge enables exceptional sensitivity and selectivity for EV-derived miRNAs and mRNAs. This approach streamlines detection with minimal plasma volume (20 ÂľL) and eliminates the need for prior EV isolation or RNA preparation, preventing loss of EVs or RNA. In testing with 83 patient samples, EV-CLIP detected EGFR L858R and T790M mutations with high AUC values of 1.0000 and 0.9784, respectively. Its success in serial monitoring during chemotherapy highlights its potential for precise quantification of rare EV subpopulations, facilitating the exploration of single EV RNA content and enhancing understanding of diverse EV populations in various disease states. SUMMARY EV-CLIP: A highly sensitive digital method for tumor-derived EV RNA detection using undiluted blood plasma samples, promising for precise tumor management.
- 7 November 2023
- Published by Wiley in Advanced Healthcare Materials
- Vol. 13  (2) , e2302121
Platelet MembraneâEnclosed Bioorthogonal Catalysis for Combating Dental Caries
Platelets have shown promise as a means to combat bacterial infections, fostering the development of innovative therapeutic approaches. However, several challenges persist, including cargo loading issues, limited efficacy against biofilms, and concerns regarding the impact of payloads on the platelet carriers. Here, human platelet membrane vesicles (hâPMVs) encapsulating supramolecular metal catalysts (SMCs) as ânanofactoriesâ to convert prodrugs into antimicrobial compounds within close proximity to bacteria are introduced. Having established the feasibility and effectiveness of the SMCs within hâPMVs, referred to as the PLTâreactor, to activate proâantibiotic drugs (proâciprofloxacin and proâmoxifloxacin) using model organisms (Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923), the investigation is subsequently extended to oral biofilms, with a particular emphasis on Streptococcus mutans 3065. This âbind and killâ strategy demonstrates the potent antimicrobial specificity of the PLTâreactor through localized antibiotic production. hâPMVs play a pivotal role by enabling precise targeting of pathogenic biofilms on natural teeth while minimizing potential hemolytic effects. The finding indicates that platelet membraneâcloaked surfaces exhibit robust, multifaceted, and pathogenâspecific binding affinity with excellent biocompatibility, making them a promising alternative to antibodyâbased therapies for infectious diseases.
- 7 November 2023
- Published by Wiley in Advanced Healthcare Materials
- Vol. 13  (2) , e2302121
Platelet MembraneâEnclosed Bioorthogonal Catalysis for Combating Dental Caries
Platelets have shown promise as a means to combat bacterial infections, fostering the development of innovative therapeutic approaches. However, several challenges persist, including cargo loading issues, limited efficacy against biofilms, and concerns regarding the impact of payloads on the platelet carriers. Here, human platelet membrane vesicles (hâPMVs) encapsulating supramolecular metal catalysts (SMCs) as ânanofactoriesâ to convert prodrugs into antimicrobial compounds within close proximity to bacteria are introduced. Having established the feasibility and effectiveness of the SMCs within hâPMVs, referred to as the PLTâreactor, to activate proâantibiotic drugs (proâciprofloxacin and proâmoxifloxacin) using model organisms (Escherichia coli ATCC 25922 and Staphylococcus aureus ATCC 25923), the investigation is subsequently extended to oral biofilms, with a particular emphasis on Streptococcus mutans 3065. This âbind and killâ strategy demonstrates the potent antimicrobial specificity of the PLTâreactor through localized antibiotic production. hâPMVs play a pivotal role by enabling precise targeting of pathogenic biofilms on natural teeth while minimizing potential hemolytic effects. The finding indicates that platelet membraneâcloaked surfaces exhibit robust, multifaceted, and pathogenâspecific binding affinity with excellent biocompatibility, making them a promising alternative to antibodyâbased therapies for infectious diseases.
- Open Access
- 19 February 2023
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 14  (2) , 117
Tuning the Extracellular Vesicles Membrane through Fusion for Biomedical Applications
Membrane fusion is one of the key phenomena in the living cell for maintaining the basic function of life. Extracellular vesicles (EVs) have the ability to transfer information between cells through plasma membrane fusion, making them a promising tool in diagnostics and therapeutics. This study explores the potential applications of natural membrane vesicles, EVs, and their fusion with liposomes, EVs, and cells and introduces methodologies for enhancing the fusion process. EVs have a high loading capacity, bio-compatibility, and stability, making them ideal for producing effective drugs and diagnostics. The unique properties of fused EVs and the crucial design and development procedures that are necessary to realize their potential as drug carriers and diagnostic tools are also examined. The promise of EVs in various stages of disease management highlights their potential role in future healthcare.
- 19 February 2023
- Published by MDPI AG in Journal of Functional Biomaterials
- Vol. 14  (2) , 117
Open AccessTuning the Extracellular Vesicles Membrane through Fusion for Biomedical Applications
Membrane fusion is one of the key phenomena in the living cell for maintaining the basic function of life. Extracellular vesicles (EVs) have the ability to transfer information between cells through plasma membrane fusion, making them a promising tool in diagnostics and therapeutics. This study explores the potential applications of natural membrane vesicles, EVs, and their fusion with liposomes, EVs, and cells and introduces methodologies for enhancing the fusion process. EVs have a high loading capacity, bio-compatibility, and stability, making them ideal for producing effective drugs and diagnostics. The unique properties of fused EVs and the crucial design and development procedures that are necessary to realize their potential as drug carriers and diagnostic tools are also examined. The promise of EVs in various stages of disease management highlights their potential role in future healthcare.
- Open Access
- 28 May 2022
- Published by Universidad Tecnica de Manabi in International journal of health sciences
- p. 12156-12165
study for the diagnosis of asthma disease using fuzzy logic based system
There are numerous expert systems that have been designed to diagnose the severity of Asthma, infect asthma is a chronic lung disorder of with the number of suffers is still estimated only. It has previously been estimated that prevalence of asthma in India is about 30 million patients with prevalence in children, young and adult. Results of various studies shows that asthma is usually under-diagnosed in developing countries. Asthma is a chronic lung disease that blocks the airways that carries air from the lungs. This blockage in the airways causes inflammations which make the patient susceptible to irritations and allergies. The purpose of this work is to design a fuzzy rule based expert system to alleviate this hazard by diagnosing asthma at initial stage. This system has 6 input parameters "FEVI test", "Age", "Allergy Rhinitis", "Environment Factor (Pollution)", "PEF test", "Medical Factor (chronic infection)"and one output parameter which is based on the final result of system and that is defuzzified in order to provide the assessment of the possibility of asthma.
- 28 May 2022
- Published by Universidad Tecnica de Manabi in International journal of health sciences
- p. 12156-12165
Open Accessstudy for the diagnosis of asthma disease using fuzzy logic based system
There are numerous expert systems that have been designed to diagnose the severity of Asthma, infect asthma is a chronic lung disorder of with the number of suffers is still estimated only. It has previously been estimated that prevalence of asthma in India is about 30 million patients with prevalence in children, young and adult. Results of various studies shows that asthma is usually under-diagnosed in developing countries. Asthma is a chronic lung disease that blocks the airways that carries air from the lungs. This blockage in the airways causes inflammations which make the patient susceptible to irritations and allergies. The purpose of this work is to design a fuzzy rule based expert system to alleviate this hazard by diagnosing asthma at initial stage. This system has 6 input parameters "FEVI test", "Age", "Allergy Rhinitis", "Environment Factor (Pollution)", "PEF test", "Medical Factor (chronic infection)"and one output parameter which is based on the final result of system and that is defuzzified in order to provide the assessment of the possibility of asthma.
- Open Access
Circulating Tumor Cell Clusters Are Cloaked with Platelets and Correlate with Poor Prognosis in Unresectable Pancreatic Cancer
Circulating tumor cells (CTCs) are known to be heterogeneous and clustered with tumor-associated cells, such as macrophages, neutrophils, fibroblasts, and platelets. However, their molecular profile and clinical significance remain largely unknown. Thus, we aimed to perform a comprehensive gene expression analysis of single CTCs and CTC clusters in patients with pancreatic cancer and to identify their potential clinical relevance to provide personalized medicine. Epitope-independent, rapid (>3 mL of whole blood/min) isolation of single CTCs and CTC clusters was achieved from a prospective cohort of 16 patients with unresectable pancreatic cancer using a centrifugal microfluidic device. Forty-eight mRNA expressions of individual CTCs and CTC clusters were analyzed to identify pancreatic CTC phenotype. CTC clusters had a larger proportion of mesenchymal expression than single CTCs (p = 0.0004). The presence of CTC clusters positively correlated with poor prognosis (progression-free survival, p = 0.0159; overall survival, p = 0.0186). Furthermore, we found that most CTCs in these patients (90.7%) were cloaked with platelets and found the presence of a positive correlation between the increase in CTC clusters and rapid disease progression during follow-ups. Efficient CTC cluster isolation and analysis techniques will enhance the understanding of complex tumor metastasis processes and can facilitate personalized disease management.
Open AccessCirculating Tumor Cell Clusters Are Cloaked with Platelets and Correlate with Poor Prognosis in Unresectable Pancreatic Cancer
Circulating tumor cells (CTCs) are known to be heterogeneous and clustered with tumor-associated cells, such as macrophages, neutrophils, fibroblasts, and platelets. However, their molecular profile and clinical significance remain largely unknown. Thus, we aimed to perform a comprehensive gene expression analysis of single CTCs and CTC clusters in patients with pancreatic cancer and to identify their potential clinical relevance to provide personalized medicine. Epitope-independent, rapid (>3 mL of whole blood/min) isolation of single CTCs and CTC clusters was achieved from a prospective cohort of 16 patients with unresectable pancreatic cancer using a centrifugal microfluidic device. Forty-eight mRNA expressions of individual CTCs and CTC clusters were analyzed to identify pancreatic CTC phenotype. CTC clusters had a larger proportion of mesenchymal expression than single CTCs (p = 0.0004). The presence of CTC clusters positively correlated with poor prognosis (progression-free survival, p = 0.0159; overall survival, p = 0.0186). Furthermore, we found that most CTCs in these patients (90.7%) were cloaked with platelets and found the presence of a positive correlation between the increase in CTC clusters and rapid disease progression during follow-ups. Efficient CTC cluster isolation and analysis techniques will enhance the understanding of complex tumor metastasis processes and can facilitate personalized disease management.
- 13 September 2021
- Published by Springer Nature in Nature Catalysis
- Vol. 4  (9) , 763-774
Programmed exosome fusion for energy generation in living cells
- 13 September 2021
- Published by Springer Nature in Nature Catalysis
- Vol. 4  (9) , 763-774
Programmed exosome fusion for energy generation in living cells
- 18 May 2020
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 4  (6) , 591-600
A fidget spinner for the point-of-care diagnosis of urinary tract infection
The point-of-care detection of pathogens in biological samples in resource-limited settings should be inexpensive, rapid, portable, simple and accurate. Here, we describe a custom-made fidget spinner that rapidly concentrates pathogens in 1-ml samples of undiluted urine by more than 100-fold for the on-device colorimetric detection of bacterial load and pathogen identification. In Tiruchirappalli, India, the device enabled the on-site detection of infection with the naked eye within 50 min in urine samples from 39 patients suspected of having a urinary tract infection. We also show that, in 30 clinical samples of urinary tract infection, the device can be used to perform an antimicrobial susceptibility test for the antimicrobial drugs ciprofloxacin and cefazolin within 120 min. The fidget spinner could be used in low-resource settings as an inexpensive handheld point-of-care device for the rapid concentration and detection of pathogens in urine samples.
- 18 May 2020
- Published by Springer Nature in Nature Biomedical Engineering
- Vol. 4  (6) , 591-600
A fidget spinner for the point-of-care diagnosis of urinary tract infection
The point-of-care detection of pathogens in biological samples in resource-limited settings should be inexpensive, rapid, portable, simple and accurate. Here, we describe a custom-made fidget spinner that rapidly concentrates pathogens in 1-ml samples of undiluted urine by more than 100-fold for the on-device colorimetric detection of bacterial load and pathogen identification. In Tiruchirappalli, India, the device enabled the on-site detection of infection with the naked eye within 50 min in urine samples from 39 patients suspected of having a urinary tract infection. We also show that, in 30 clinical samples of urinary tract infection, the device can be used to perform an antimicrobial susceptibility test for the antimicrobial drugs ciprofloxacin and cefazolin within 120 min. The fidget spinner could be used in low-resource settings as an inexpensive handheld point-of-care device for the rapid concentration and detection of pathogens in urine samples.